会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 4-azasteroids with side-chain fluoroketones
    • 具有侧链含氟酮的4-azasteroids
    • US5719159A
    • 1998-02-17
    • US615242
    • 1996-05-31
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • A61K31/59A61P3/00C07J3/00C07J73/00A61K31/58C07D221/02
    • C07J73/005
    • The present invention provides compounds of formula (D wherein the symbol - - - represents a single or a double bond; R is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; A is a single bond or a straight or branched C.sub.1 -C.sub.6 alkylene chain; B is a straight or branched C.sub.1 -C.sub.12 alkylene group optionally substituted by one or more aryl groups or fluorine atoms; W is a group R.sub.1 or (a) wherein R.sub.1 is a straight or branched C.sub. -C.sub.6 alkyl group unsubstituted or substituted by one or more fluorine atoms, provided that at least a fluorine atom is present in B or W. The compounds of the invention are useful as testosterone 5.alpha.-reductase inhibitors. ##STR1##
    • PCT No.PCT / EP95 / 02649第 371日期:1996年5月31日 102(e)日期1996年5月31日PCT提交1995年7月7日PCT公布。 出版物WO96 / 03422 日期:1996年2月8日本发明提供了式(D的化合物,其中符号+ E,不 - + EE表示单键或双键; R是氢原子或C1-C4烷基; A是 单键或直链或支链C1-C6亚烷基链; B是任选被一个或多个芳基或氟原子取代的直链或支链C 1 -C 12亚烷基; W是基团R 1或(a)其中R 1是直链 或未被取代或被一个或多个氟原子取代的支链C 1 -C 6烷基,条件是至少在B或W中存在氟原子。本发明的化合物可用作睾酮5α-还原酶抑制剂。
    • 2. 发明授权
    • Phenylsubstituted 4-azasteroid fluoroderivatives
    • 苯基取代的4-azasteroid氟代衍生物
    • US5922728A
    • 1999-07-13
    • US836052
    • 1997-05-13
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • A61K31/58A61P43/00C07J73/00C07D221/18
    • C07J73/005
    • Compounds of formula (I), wherein: the symbol represents a single or a double bond; R is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; R.sub.f and R'.sub.f, each independently, are C.sub.1 -C.sub.4 alkyl groups substituted by one or more fluorine atoms; and R.sub.1 and R.sub.2, each independently, are selected from: a hydrogen atom; a phenyl group; a C.sub.1 -C.sub.4 alkyl group unsubstituted or substituted by one or more fluorine atoms; a halogen atom; a cyano (CN) group; a group OR.sub.4, wherein R.sub.4 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; a group SR.sub.5, wherein R.sub.5 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; and a group COR.sub.6, wherein R.sub.6 is a group OR.sub.4 in which R.sub.4 is as defined above or a C.sub.1 -C.sub.4 alkyl group unsubstituted or substituted by one or more fluorine atoms. They are useful as testosterone 5a-reductase inhibitors.
    • PCT No.PCT / EP96 / 03518 Sec。 371日期1997年5月13日 102(e)日期1997年5月13日PCT提交1996年8月9日PCT公布。 第WO97 / 10257号公报 日期1997年3月20日式(I)化合物,其中:符号+ Z表示单键或双键; R是氢原子或C 1 -C 4烷基; Rf和R'f各自独立地是被一个或多个氟原子取代的C 1 -C 4烷基; 并且R 1和R 2各自独立地选自:氢原子; 苯基; 未被取代或被一个或多个氟原子取代的C 1 -C 4烷基; 卤素原子; 氰基(CN)基团; OR 4,其中R 4是氢原子或C 1 -C 4烷基; 基团SR5,其中R5是氢原子或C1-C4烷基; 和基团COR6,其中R6是其中R4如上定义的基团OR4或未被取代或被一个或多个氟原子取代的C 1 -C 4烷基。 它们可用作睾酮5a还原酶抑制剂。
    • 3. 发明授权
    • Unsaturated 17.beta.-subsituted 3-carboxy steroids
    • 不饱和的17(BETA) - 使用的3-CARBOXY STEROIDS
    • US5212166A
    • 1993-05-18
    • US886574
    • 1992-05-21
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • A61K31/565A61K31/56A61K31/58A61P5/24A61P5/28A61P13/02A61P15/00A61P17/00A61P17/02A61P17/14A61P35/00A61P43/00C07J20060101C07J41/00C07J43/00
    • C07J43/003C07J41/0066
    • The present invention concerns steroidic 5.alpha.-reductase inhibitors having the following formula (I) ##STR1## wherein Y is oxygen or sulphur;R is a group;a) --OR.sub.4, wherein R.sub.4 is hydrogen or a C.sub.1 -C.sub.6 alkyl group;b) ##STR2## wherein each of R.sub.5 and R.sub.6, independently, is hydrogen or a C.sub.1 -C.sub.6 alkyl group;c) ##STR3## wherein R.sub.7 is hydrogen or a C.sub.1 -C.sub.6 alkyl group and W is a group:(i) ##STR4## wherein R.sub.8 is a C.sub.1 -C.sub.6 alkyl group, a C.sub.5 -C.sub.6 cycloalky group, a C.sub.6 -C.sub.6 cycloalkylalkyl group, a phenyl group or a benzyl group; or(ii) ##STR5## wherein R.sub.9 is a C.sub.1 -C.sub.6 alkyl group or a C.sub.5 -C.sub.6 cycloalkyl group; or(iii) ##STR6## wherein R.sub.5 and R.sub.6 are as defined above; d) ##STR7## wherein each of R.sub.10 and R.sub.11 is, independently, hydrogen or a C.sub.1 -C.sub.6 alkyl group or taken together with the nitrogen atom to which they are linked form a pentatomic or hexatomic saturated heteromonocyclic ring, optionally containing at least one additional heteroatom selected from oxygen and nitrogen, and n is an integer of 2 to 4;R.sub.1 is hydrogen, a C.sub.1 -C.sub.6 alkyl group, a C.sub.5 -C.sub.6 cycloalkyl group, a C.sub.6 -C.sub.9 cycloalkyalkyl group or an aryl group;each of R.sub.2 and R.sub.3 is, independently, selected from the group consisting of hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.5 -C.sub.6 cycloalkyl, C.sub.6 -C.sub.9 cycloalkylalkyl and aryl or R.sub.2 and R.sub.3, taken together with the nitrogen atom to which they are linked, form a pentatomic or hexatomic saturated heteromonocyclic ring, optionally containing at least one additional heteroatom selected from oxygen and nitrogen; and the symbol ( ) represents a single or a double bond provided that when it is a double bond the hydrogen in the 5.alpha. position doesn't exist and the pharmaceutically acceptable salts thereof.In view of their 5-.alpha. reductase inhibiting activity the compounds of the invention can be useful for the treatment of androgen dependent conditions.
    • 4. 发明授权
    • Phenylsubstituted 4-azasteroid fluoroderivatives
    • 苯基取代的4-azasteroid氟代衍生物
    • US6114345A
    • 2000-09-05
    • US300454
    • 1999-04-28
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • A61K31/58A61P43/00C07J73/00
    • C07J73/005
    • Compounds of formula (I), wherein: the symbol ---- represents a single or a double bond; R is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; R.sub.f and R'.sub.f, each independently, are C.sub.1 -C.sub.4 alkyl groups substituted by one or more fluorine atoms; and R.sub.1 and R.sub.2, each independently, are selected from: a hydrogen atom; a phenyl group; a C.sub.1 -C.sub.4 alkyl group unsubstituted or substituted by one or more fluorine atoms; a halogen atom; a cyano (CN) group; a group OR.sub.4, wherein R.sub.4 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; a group SR.sub.5, wherein R.sub.5 is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; and a group COR.sub.6, wherein R.sub.6 is a group OR.sub.4 in which R.sub.4 is as defined above or a C.sub.1 -C.sub.4 alkyl group unsubstituted or substituted by one or more fluorine atoms. They are useful as testosterone 5a-reductase inhibitors.
    • 式(I)的化合物,其中:符号+ E,uns ---- + EE表示单键或双键; R是氢原子或C 1 -C 4烷基; Rf和R'f各自独立地是被一个或多个氟原子取代的C 1 -C 4烷基; 并且R 1和R 2各自独立地选自:氢原子; 苯基; 未被取代或被一个或多个氟原子取代的C 1 -C 4烷基; 卤素原子; 氰基(CN)基团; OR 4,其中R 4是氢原子或C 1 -C 4烷基; 基团SR5,其中R5是氢原子或C1-C4烷基; 和基团COR6,其中R6是其中R4如上定义的基团OR4或未被取代或被一个或多个氟原子取代的C 1 -C 4烷基。 它们可用作睾酮5a还原酶抑制剂。
    • 5. 发明授权
    • Fluorinated 17 .beta.-substituted 4-aza-5 .alpha.-androstan-3-one
derivatives
    • 氟化17β-取代的4-氮杂-5α-雄甾烷-3-酮衍生物
    • US5407939A
    • 1995-04-18
    • US98729
    • 1993-07-29
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • Achille PanzeriMarcella NesiEnrico Di Salle
    • A61K31/58A61P5/28A61P17/00A61P17/08A61P17/14A61P35/00C07J73/00C12N9/99A61K31/47
    • C07J73/005
    • Compounds of formula (I) ##STR1## wherein: the symbol represents a single or a double bond;B is a bond or a straight or branched C.sub.1 -C.sub.6 alkylene chain;R is hydrogen or C.sub.1 -C.sub.4 alkyl;R.sub.1 is hydrogen, C.sub.1 -C.sub.6 alkyl or benzyl;R.sub.2 isa) hydrogen, fluorine, C.sub.1 -C.sub.6 alkyl, C.sub.5 -C.sub.7 cycloalkyl or C.sub.6 -C.sub.9 cycloalkylalkyl; orb) aryl or C.sub.7 -C.sub.10 arylalkyl;R.sub.3 isa) hydrogen, fluorine or C.sub.1 -C.sub.4 alkyl; orb) aryl or C.sub.7 -C.sub.10 arylalkyl;R.sub.4 is hydrogen, fluorine, or is absent when Y is a double bond;R.sub.5 is hydrogen, fluorine or C.sub.1 -C.sub.6 alkyl; and when Y is a single bond, A is hydrogen, fluorine or ##STR2## wherein each of R.sub.6, R.sub.7 and R.sub.8 independently is hydrogen, fluorine or C.sub.1 -C.sub.6 alkyl; and when Y is a double bond, A is a ##STR3## wherein each of R.sub.6 and R.sub.7 is independently hydrogen, fluorine or C.sub.1 -C.sub.6 alkyl; with the proviso that at least one of the groups R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 or A contains at least one fluorine atom.
    • 式(I)化合物其中:符号表示单键或双键; B是键或直链或支链C1-C6亚烷基链; R是氢或C 1 -C 4烷基; R1是氢,C1-C6烷基或苄基; R2是a)氢,氟,C1-C6烷基,C5-C7环烷基或C6-C9环烷基烷基; 或b)芳基或C7-C10芳基烷基; R3是a)氢,氟或C1-C4烷基; 或b)芳基或C7-C10芳基烷基; R4是氢,氟,或当Y是双键时不存在; R5是氢,氟或C1-C6烷基; 当Y是单键时,A是氢,氟或者其中R6,R7和R8各自独立地是氢,氟或C1-C6烷基; 当Y是双键时,A是一个,其中R6和R7各自独立地是氢,氟或C1-C6烷基; 条件是基团R,R 1,R 2,R 3,R 4,R 5或A中的至少一个含有至少一个氟原子。
    • 10. 发明授权
    • Ergoline derivatives and a process for their preparation
    • 艾尔莫林衍生物及其制备方法
    • US4196288A
    • 1980-04-01
    • US856536
    • 1977-12-01
    • Enzo BeaccoLuigi BernardiEnrico Di SalleGiovanni FalconiBianca Patelli
    • Enzo BeaccoLuigi BernardiEnrico Di SalleGiovanni FalconiBianca Patelli
    • A61K31/48A61K31/495A61K31/505C07D457/02
    • C07D457/02
    • New ergoline derivatives are disclosed which are compounds of formula (I) having the structure: ##STR1## wherein R.sub.1 is hydrogen or methoxy; R.sub.2 is hydrogen or methyl; andX is hydroxy, R.sub.3 COO, S--R.sub.4 or NR.sub.5 R.sub.6 in which R.sub.3 is a straight or branched alkyl having from 1 to 6 carbon atoms, unsubstituted- or substituted-phenyl, the substituents being selected from the class consisting of chlorine, bromine, alkyl or alkoxy having from 1 to 4 carbon atoms, cycloalkyl containing from 3 to 6 carbon atoms, or a heterocycle;R.sub.4 is phenyl or a heterocycle, andR.sub.5 and R.sub.6 are alkyl having from 1 to 4 carbon atoms, or together with the N atom to which they are attached, forming a heterocycle. The heterocycle may be a 5- or 6-membered ring which contains from 1 to 3 hetero atoms selected from the class consisting of nitrogen, oxygen and sulphur, and may be saturated or unsaturated, and unsubstituted or substituted by halogen, alkyl having from 1 to 3 carbon atoms, hydroxy, nitro, amino, CONHNH.sub.2 and COOH.
    • 公开了新的麦角灵衍生物,其是具有以下结构的式(I)的化合物:其中R 1是氢或甲氧基; R2是氢或甲基; 并且X是羟基,R 3 COO,S-R 4或NR 5 R 6,其中R 3是具有1至6个碳原子的直链或支链烷基,未取代或取代的苯基,所述取代基选自氯,溴,烷基 或具有1至4个碳原子的烷氧基,含3至6个碳原子的环烷基或杂环; R 4是苯基或杂环,R 5和R 6是具有1至4个碳原子的烷基,或与它们相连的N原子一起形成杂环。 杂环可以是含有1至3个选自氮,氧和硫的杂原子的5或6元环,并且可以是饱和或不饱和的,未取代的或被卤素取代的烷基,具有1个 至3个碳原子,羟基,硝基,氨基,CONHNH 2和COOH。